Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

References for PMC Articles for PubMed (Select 19995892)

1.

Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.

Weimer ET, Ervin SE, Wozniak DJ, Mizel SB.

Vaccine. 2009 Nov 12;27(48):6762-9. doi: 10.1016/j.vaccine.2009.08.080. Epub 2009 Sep 8.

PMID:
19744586
2.

A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.

Weimer ET, Lu H, Kock ND, Wozniak DJ, Mizel SB.

Infect Immun. 2009 Jun;77(6):2356-66. doi: 10.1128/IAI.00054-09. Epub 2009 Apr 6.

3.

Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin.

Ramphal R, Balloy V, Jyot J, Verma A, Si-Tahar M, Chignard M.

J Immunol. 2008 Jul 1;181(1):586-92.

4.

Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice.

Scarff JM, Goldberg JB.

Clin Vaccine Immunol. 2008 Feb;15(2):367-75. Epub 2007 Dec 19.

5.
6.

Modulation of corneal epithelial innate immune response to pseudomonas infection by flagellin pretreatment.

Kumar A, Yin J, Zhang J, Yu FS.

Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4664-70.

7.

Blocking of the TLR5 activation domain hampers protective potential of flagellin DNA vaccine.

Saha S, Takeshita F, Matsuda T, Jounai N, Kobiyama K, Matsumoto T, Sasaki S, Yoshida A, Xin KQ, Klinman DM, Uematsu S, Ishii KJ, Akira S, Okuda K.

J Immunol. 2007 Jul 15;179(2):1147-54.

8.

A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients.

Döring G, Meisner C, Stern M; Flagella Vaccine Trial Study Group.

Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11020-5. Epub 2007 Jun 21.

9.

The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa.

Balloy V, Verma A, Kuravi S, Si-Tahar M, Chignard M, Ramphal R.

J Infect Dis. 2007 Jul 15;196(2):289-96. Epub 2007 Jun 11.

10.

Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections.

DiGiandomenico A, Rao J, Harcher K, Zaidi TS, Gardner J, Neely AN, Pier GB, Goldberg JB.

Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4624-9. Epub 2007 Mar 5.

11.

Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa.

Skerrett SJ, Wilson CB, Liggitt HD, Hajjar AM.

Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L312-22. Epub 2006 Aug 25.

12.

Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria.

Feuillet V, Medjane S, Mondor I, Demaria O, Pagni PP, Galán JE, Flavell RA, Alexopoulou L.

Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12487-92. Epub 2006 Aug 4.

13.

Glycosylation of b-Type flagellin of Pseudomonas aeruginosa: structural and genetic basis.

Verma A, Schirm M, Arora SK, Thibault P, Logan SM, Ramphal R.

J Bacteriol. 2006 Jun;188(12):4395-403.

15.

Role of motility and flagellin glycosylation in the pathogenesis of Pseudomonas aeruginosa burn wound infections.

Arora SK, Neely AN, Blair B, Lory S, Ramphal R.

Infect Immun. 2005 Jul;73(7):4395-8.

16.

Cell activation by Toll-like receptors: role of LBP and CD14.

Finberg RW, Re F, Popova L, Golenbock DT, Kurt-Jones EA.

J Endotoxin Res. 2004;10(6):413-8.

PMID:
15588424
18.
19.

Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility.

Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, Barrett SL, Cookson BT, Aderem A.

Nat Immunol. 2003 Dec;4(12):1247-53. Epub 2003 Nov 16. Erratum in: Nat Immunol. 2004 Apr;5(4):451.

PMID:
14625549
20.

A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa.

Dasgupta N, Wolfgang MC, Goodman AL, Arora SK, Jyot J, Lory S, Ramphal R.

Mol Microbiol. 2003 Nov;50(3):809-24.

PMID:
14617143
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk